Diabetic Ketoacidosis in Patients With COVID-19.

Rao, Sanjana; Ali, Kiran; Rivas, Marcella; Nugent, Kenneth

Rao, Sanjana; Ali, Kiran; Rivas, Marcella; Nugent, Kenneth.

Rao S; Deaprtment of Internal Medicine, Texas Tech University Health Sciences Center, 3601 4th Street, Lubbock, TX 79430, United States.
Ali K; Deaprtment of Internal Medicine, Texas Tech University Health Sciences Center, 3601 4th Street, Lubbock, TX 79430, United States.
Rivas M; CoxHealth Adult Medicine & Endocrinology Specialists, Springfield, MO, United States.
Nugent K; Deaprtment of Internal Medicine, Texas Tech University Health Sciences Center, 3601 4th Street, Lubbock, TX 79430, United States. Electronic address: Kenneth.nugent@ttuhsc.edu.

Am J Med Sci ; 361(5): 668-669, 2021 05.

Article in English | MEDLINE | ID: covidwho-1240151

Subject(s)

COVID-19 Drug Treatment; COVID-19; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; SARS-CoV-2/metabolism; Adult; COVID-19/blood; COVID-19/complications; Diabetes Mellitus, Type 1/blood; Diabetes Mellitus, Type 1/drug therapy; Diabetic Ketoacidosis/blood; Diabetic Ketoacidosis/drug therapy; Diabetic Ketoacidosis/etiology; Female; Humans; Male; Middle Aged

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetic Ketoacidosis / Diabetes Mellitus, Type 1 / SARS-CoV-2 / COVID-19 / COVID-19 Drug Treatment Topics: Long Covid Limits: Adult / Female / Humans / Male / Middle aged Language: English Journal: Am J Med Sci Year: 2021 Document Type: Article Affiliation country: J.amjms.2020.11.027

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google